Hopital Paul Brousse   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Villejuif France (1913)

Organization Overview

First Clinical Trial
1997
NCT00003029
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

APHP, Paul Brousse Hospital, villejuif, France | Geriatric Department - Paul Brousse Hospital | Hepatobiliary Center of Paul Brousse Hospital. France | Hopital Paul Brousse | Hospital Paul Brousse | Hospital Paul Brousse, Centre Hepato-Biliaire | Institut de Cancerologie et D'Immunogenetique at Hopital Paul-Brousse | Paul Brousse hospital | Paul Brousse Hospital, Villejuif | Paul Brousse Hospital, Villejuif, France

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cocaine-Related Disorders (Phase 2)

Colorectal Neoplasms (Phase 3)

Fibrosis (Phase 2)

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis B (Phase 3)

Hepatitis C (Phase 2)

Liver Cirrhosis (Phase 2)

Liver Cirrhosis, Experimental (Phase 2)

Liver Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms, Second Primary (Phase 2)

Pancreatic Neoplasms (Phase 3)

Substance-Related Disorders (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 11